Patients Expect More Info About Tests Involving Radiation

Share this content:
Patients Expect More Info About Tests Involving Radiation
Patients Expect More Info About Tests Involving Radiation

WEDNESDAY, March 25, 2015 (HealthDay News) -- There is a considerable gap between patient expectations and current practices for provision of information relating to radiation use in medical imaging tests, according to a special report published online March 24 in Radiology.

Raymond H. Thornton, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues identified opportunities for improving patient-centered communication about diagnostic imaging tests that involve use of radiation in cancer care. The authors examined patient knowledge, information sources, and communication preferences in six focus groups conducted during 2012.

The researchers found that most participants reported that their health care providers did not initiate discussions about benefits and risks of radiation from imaging tests, although participants were aware of the long-term risk of cancer from exposure to ionizing radiation. Most of the patients reported obtaining information via self-directed Internet searches. Participants conveyed gratitude for tests but expressed concern about having to initiate discussions and the desire to be informed about the rationale for ordering specific imaging examinations, intervals for follow-up testing, and alternatives to testing. Participants believed that such information should be readily available; conversations with their personal physicians or endorsed reference materials were considered ideal for information exchange. The importance of understanding imaging radiation risks and active participation in decision making were emphasized by cancer survivors.

"A substantial gap exists between patient expectations and current practices for providing information about medical imaging tests that involve the use of radiation," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths